PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Under-fire Unilever culls 1,500 management jobs as it reshapes

Tue, 25th Jan 2022 09:22

* To create five product-focused divisions

* Long-planned revamp comes after failed bid for GSK unit

* Comes amid news of stakebuilding by activist investor
(Adds graphic, comments from analyst and restructuring expert)

By Richa Naidu and Pushkala Aripaka

LONDON, Jan 25 (Reuters) - Unilever unveiled plans
on Tuesday to cut about 1,500 management jobs in a restructuring
aimed at easing shareholders' concerns after a failed
acquisition and reports an activist investor has built a stake
in the consumer goods giant.

The maker of Dove soap and Magnum ice cream, which employs
about 149,000 people worldwide, said on Tuesday the revamp would
create five product-focused divisions - beauty and wellbeing,
personal care, home care, nutrition, and ice cream.

The move, which Unilever said had been in the works over the
past year, echoes the reshaping by rival Procter & Gamble (P&G)
three years ago https://www.reuters.com/article/us-procter-gamble-strategy-idUKKCN1ND37M
when it created six similar business units, in its biggest
reorganisation in two decades.

"Moving to five category-focused business groups will enable
us to be more responsive to consumer and channel trends, with
crystal-clear accountability for delivery," Unilever CEO Alan
Jope said.

Unilever, whose shares have fallen by about a quarter from
their record high in 2019, last week effectively abandon https://www.reuters.com/business/retail-consumer/unilever-says-it-will-not-increase-50-bln-pound-offer-gsk-consumer-business-2022-01-19ed
plans to buy GlaxoSmithKline's (GSK) consumer
healthcare business for 50 billion pounds ($67 billion).

Its proposal, rejected by GSK, was widely criticised by
investors as being a costly and risky distraction from dealing
with pressing challenges to the business, such as surging
inflation in emerging markets and weakness in healthy foods.

Days later, reports also emerged activist investor Nelson
Peltz's Trian Partners had been building a stake in Unilever,
mirroring a previous investment and push for change at P&G and
other consumer goods companies. Trian has not confirmed that it
has built a stake in Unilever.

"The decision to cut 1,500 jobs globally shows the
significant pressure that Unilever is currently under," Sean
Moran, restructuring specialist at law firm Shakespeare
Martineau, said.

"While today’s news may not be directly connected to the
company’s failed GSK offer, the timing is unfortunate ... When
confidence in a business is low, drastic decisions must often be
made."

REFOCUSING

At P&G, Trian criticized the Tide detergent maker's falling
market share, low organic sales growth, aging brands,
bureaucracy and excessive structural costs, among other things.

"It just happens to be right now that Unilever is in the
fray," Barclays analyst Warren Ackerman said. "Peltz has tried
at Mondelez, Heinz, PepsiCo - a whole catalogue of consumer
goods companies."

Some investors think Unilever focuses too much on
environmental and social strategies and not enough on its core
business, he added.

On Thursday, influential British fund manager Terry Smith
criticised Unilever in a letter to his Fundsmith LLP investors,
calling the lost GSK deal a "near death experience" and urging
the company's management to focus on strengthening performance.

Smith criticised Unilever's "penchant for corporate
gobbledegook as substitute for effective action."

"The company would benefit from focusing its attention on
strengthening its current product ranges and reaching new and
existing customers, instead of diversifying into other sectors
such as healthcare — as seen in the GSK bid," GlobalData analyst
Ramsey Baghdadi said.

Unilever, which traces its roots to a small soap business in
1880s Britain, said it does not expect factory workers to be
impacted by the restructuring.

(Reporting by Richa Naidu in London and Pushkala Aripaka in
Bengaluru
Editing by Mark Potter)

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.